Production of high-titer transmission-defective RNA virus-based episomal vector using tangential flow filtration

被引:1
|
作者
Komatsu, Yumiko [1 ,2 ]
Kakuya, Yoji [1 ,3 ]
Tomonaga, Keizo [1 ,3 ,4 ]
机构
[1] Kyoto Univ, Inst Frontier Life & Med Sci InFront, Dept Virus Res, Lab RNA Viruses, Kyoto, Japan
[2] Kyoto Univ, Keihanshin Consortium Fostering Next Generat Glob, Kyoto, Japan
[3] Kyoto Univ, Grad Sch Biostudies, Dept Mammalian Regulatory Network, Kyoto, Japan
[4] Kyoto Univ, Grad Sch Med, Dept Mol Virol, Kyoto, Japan
关键词
high-titer; in vivo gene delivery; RNA virus-based episomal vector; tangential flow filtration; viral vector; LARGE-SCALE PRODUCTION; LENTIVIRAL VECTORS; GENE-TRANSFER; HIGH-YIELD; PURIFICATION; SYSTEM; TRANSDUCTION; TYPE-2; RAAV;
D O I
10.1111/1348-0421.12831
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In recent years, viral vector based in vivo gene delivery strategies have achieved a significant success in the treatment of genetic diseases. RNA virus-based episomal vector lacking viral glycoprotein gene (Delta G-REVec) is a nontransmissive gene delivery system that enables long-term gene expression in a variety of cell types in vitro, yet in vivo gene delivery has not been successful due to the difficulty in producing high titer vector. The present study showed that tangential flow filtration (TFF) can be effectively employed to increase the titer of Delta G-REVec. Concentration and diafiltration of Delta G-REVec using TFF significantly increased its titer without loss of infectious activity. Importantly, intracranial administration of high titer vector enabled persistent transgene expression in rodent brain.
引用
收藏
页码:602 / 609
页数:8
相关论文
共 37 条
  • [1] In vivo biodistribution analysis of transmission competent and defective RNA virus-based episomal vector
    Komatsu, Yumiko
    Tanaka, Chiaki
    Komorizono, Ryo
    Tomonaga, Keizo
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [2] In vivo biodistribution analysis of transmission competent and defective RNA virus-based episomal vector
    Yumiko Komatsu
    Chiaki Tanaka
    Ryo Komorizono
    Keizo Tomonaga
    Scientific Reports, 10
  • [3] Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration
    Goebel, Sven
    Pelz, Lars
    Silva, Cristina A. T.
    Bruhlmann, Bela
    Hill, Charles
    Altomonte, Jennifer
    Kamen, Amine
    Reichl, Udo
    Genzel, Yvonne
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2024, 108 (01)
  • [4] Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration
    Sven Göbel
    Lars Pelz
    Cristina A. T. Silva
    Béla Brühlmann
    Charles Hill
    Jennifer Altomonte
    Amine Kamen
    Udo Reichl
    Yvonne Genzel
    Applied Microbiology and Biotechnology, 2024, 108
  • [5] Development of an RNA virus-based episomal vector with artificial aptazyme for gene silencing
    Komorizono, Ryo
    Yoshizumi, Shima
    Tomonaga, Keizo
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2024, 108 (01)
  • [6] Development of an RNA Virus-Based Episomal Vector Capable of Switching Transgene Expression
    Yamamoto, Yusuke
    Tomonaga, Keizo
    Honda, Tomoyuki
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [7] Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency
    Nasimuzzaman, Md
    Lynn, Danielle
    Ernst, Rebecca
    Beuerlein, Michele
    Smith, Richard H.
    Shrestha, Archana
    Cross, Scott
    Link, Kevin
    Lutzko, Carolyn
    Nordling, Diana
    Russell, David W.
    Larochelle, Andre
    Malik, Punam
    Van der Loo, Johannes C. M.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2016, 3 : 16004
  • [8] High-Titer Herpes Simplex Virus Type 1-Based Vector Manufacturing Using Univercells Technologies' Production System
    Tang, Lingjing
    Wang, Jun
    Fang, Zihao
    Gao, Han
    Wei, Houliang
    You, Qingrui
    Jia, Guodong
    MOLECULAR THERAPY, 2022, 30 (04) : 361 - 361
  • [9] A novel RNA virus-based episomal vector system for long-term stem cell modification
    Makino, A.
    Komorizono, R.
    Holditch, S. J.
    Lu, B.
    Honda, T.
    Ikeda, Y.
    Tomonaga, K.
    HUMAN GENE THERAPY, 2015, 26 (10) : A26 - A27
  • [10] In vivo evaluation of replication competent and defective RNA-virus based episomal vector system
    Komatsu, Y.
    Tanaka, C.
    Tomonaga, K.
    HUMAN GENE THERAPY, 2019, 30 (11) : A197 - A198